CA2215800C - Formulation auto-emulsifiante produisant un emulsion positivement charge - Google Patents

Formulation auto-emulsifiante produisant un emulsion positivement charge Download PDF

Info

Publication number
CA2215800C
CA2215800C CA002215800A CA2215800A CA2215800C CA 2215800 C CA2215800 C CA 2215800C CA 002215800 A CA002215800 A CA 002215800A CA 2215800 A CA2215800 A CA 2215800A CA 2215800 C CA2215800 C CA 2215800C
Authority
CA
Canada
Prior art keywords
pharmaceutical composition
oil
composition according
seof
oily
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002215800A
Other languages
English (en)
Other versions
CA2215800A1 (fr
Inventor
Simon Benita
Jackie Kleinstern
Tatyana Gershanik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yissum Research Development Co of Hebrew University of Jerusalem
Original Assignee
Yissum Research Development Co of Hebrew University of Jerusalem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Research Development Co of Hebrew University of Jerusalem filed Critical Yissum Research Development Co of Hebrew University of Jerusalem
Priority to CA002215800A priority Critical patent/CA2215800C/fr
Priority claimed from PCT/FR1995/000531 external-priority patent/WO1996033697A1/fr
Publication of CA2215800A1 publication Critical patent/CA2215800A1/fr
Application granted granted Critical
Publication of CA2215800C publication Critical patent/CA2215800C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Colloid Chemistry (AREA)
CA002215800A 1995-04-24 1995-04-24 Formulation auto-emulsifiante produisant un emulsion positivement charge Expired - Fee Related CA2215800C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002215800A CA2215800C (fr) 1995-04-24 1995-04-24 Formulation auto-emulsifiante produisant un emulsion positivement charge

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002215800A CA2215800C (fr) 1995-04-24 1995-04-24 Formulation auto-emulsifiante produisant un emulsion positivement charge
PCT/FR1995/000531 WO1996033697A1 (fr) 1995-04-24 1995-04-24 Formulation auto-emulsionnable formant une emulsion huile dans l'eau

Publications (2)

Publication Number Publication Date
CA2215800A1 CA2215800A1 (fr) 1996-10-31
CA2215800C true CA2215800C (fr) 2008-04-15

Family

ID=4161485

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002215800A Expired - Fee Related CA2215800C (fr) 1995-04-24 1995-04-24 Formulation auto-emulsifiante produisant un emulsion positivement charge

Country Status (1)

Country Link
CA (1) CA2215800C (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2243490B1 (fr) * 2007-12-28 2012-06-13 Shanghai Institute of Pharmaceutical Industry Inhalation d'une poudre à base d'insuline nasale

Also Published As

Publication number Publication date
CA2215800A1 (fr) 1996-10-31

Similar Documents

Publication Publication Date Title
US5965160A (en) Self-emulsifiable formulation producing an oil-in-water emulsion
EP0315079B1 (fr) Supports de médicaments
EP0711550B1 (fr) Compositions pour capsule molle à base de cyclosporine
ES2326783T3 (es) Composiciones de n-benzoilestaurosporina espontaneamente dispersables.
US20120087959A1 (en) Nanodispersion of a drug and process for its preparation
AU2006222117B2 (en) Microemulsions of cannabinoid receptor binding compounds
DE69426570T2 (de) Mizelleförmige feinteilige pharmazeutische zusammensetzungen
TW201521719A (zh) 含有脂質化合物、三酸甘油酯及界面活性劑之組成物與使用該組成物之方法
JPH0798740B2 (ja) 薬物担体
JP2003501376A (ja) 疎水性薬物の持続性放出のための油コア組成物
US20120308663A1 (en) Lipid nanocapsules, method for preparing same and use thereof as a drug
EP0754045B1 (fr) composés contenant de l'halofantrine dans une forme spéciale
Reddy et al. Review on self micro emulsifying drug delivery systems
CN101103962A (zh) 长春西汀口服自微乳化释药系统及其制备方法
JPH0840936A (ja) 経口投与薬物のための製剤
EP1082119B1 (fr) Preconcentres de microemulsion contenant un antagoniste de la substance p a base de piperidine
CA2215800C (fr) Formulation auto-emulsifiante produisant un emulsion positivement charge
JP3132085B2 (ja) 脂肪乳剤
Garrigue et al. Self-emulsifying oral lipidbased formulations for improved delivery of lipophilic drugs
DE69418892T2 (de) Selbstemulgierende formulierung zur bildung einer öl-in-wasser-emulsion
KR100426346B1 (ko) 자가미세유화형 약물전달시스템을 이용한 고지혈증치료용약제 조성물
KR100524700B1 (ko) 자가미세유화형 약물전달시스템을 이용한 고지혈증치료용약제 조성물
WO2016066611A1 (fr) Compositions pharmaceutiques contenant du cinacalcet et procédés pour leur préparation et leur utilisation
MXPA01008293A (en) Spontaneously dispersible n-benzoyl staurosporine compositions

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed